Cardiac function, inflammatory mediators and mortality in critical limb ischemia

Angiology

Volumn 57, Issue 4, 2006, Pages 437-444

  Barani, Jamal ^a   Mattiasson, Ingrid ^a   Lindblad, Bengt ^a   Gottsäter, Anders ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; ENDOTHELIN 1; INTERLEUKIN 6; NEOPTERIN; PROSTAGLANDIN F2 ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE SIZE; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MEDIATOR RELEASE; MORTALITY; PACEMAKER; PROSPECTIVE STUDY; SINUS RHYTHM;

AGED; AGED, 80 AND OVER; ARRHYTHMIA; ECHOCARDIOGRAPHY; EXTREMITIES; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; ISCHEMIA; MALE; MYOCARDIAL ISCHEMIA; NEOPTERIN; PROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR FUNCTION, LEFT;

EID: 33749021650     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319706290743     Document Type: Article

References (41)

1. Mautner GC, Mautner SL, Roberts WC: Amounts of coronary arterial narrowing by atherosclerotic plaque at necropsy in patients with lower extremity amputation. Am J Cardiol 70:1147-1151, 1992.
2. Aronow WS, Ahn C: Prevalence of coexistence of coronary artery disease, peripheral artery disease, and atherothrombotic brain infarction in men and women 62 years of age. Am J Cardiol 74:64-65, 1994.
3. Ness J, Aronow WS: Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice. J Am Geriatr Soc 47:1255-1256, 1999.
4. Aronow WS, Ahn C: Association of valvular aortic stenosis with symptomatic peripheral arterial disease in older persons. Am J Cardiol 88:1046-1047, 2001.
5. Hertzer NR: Fatal myocardial infarction following lower extremity revascularisation - 273 patients followed 6-11 postoperative years. Ann Surg 193:492-498, 1981.
6. Fowkes FGR: Epidemiology of atherosclerotic arterial disease in the lower limbs. Eur J Vasc Surg 2:283-291, 1988.
7. Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med 340:115-126, 1999.
8. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 105:1135-1143, 2002.
9. Dormandy JA, Rutherford RB, TASC Working Group: TransAtlantic Inter-Society Consensus (TASC). Management of peripheral arterial disease (PAD). J Vasc Surg 31:5170, 2000.
10. Young JL, Libby P, Schönbeck U: Cytokines in the pathogenesis of atherosclerosis. Thromb Haemost 88:554-567, 2002.
11. Tatzber F, Rabl H, Koriska K, et al: Elevated serum neopterin levels in atherosclerosis. Atherosclerosis 89:203-208, 1991.
12. Kishimoto T: The biology of interleukin-6. Blood 74:1-10, 1989.
13. Schönbeck U, Libby P: CD40 signaling and plaque instability. Circ Res 89:1092-1103, 2001.
14. Schönbeck U, Gerdes N, Varo N, et al: Oxidized low-density lipoprotein augments and 3-hydroxy-methyl-glutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells. Circulation 106:2888-2893, 2002.
15. Newby DE, Webb DJ: The endothelin system in cardiovascular disease. Br Med J 314:531-532, 1997.
16. Ikeda U, Yamamoto K, Maeda Y, et al: Endothelin-1 inhibits nitric oxide synthesis in vascular smooth muscle cells. Hypertension 29:65-69, 1997.
17. 2α and platelet activation in diabetes mellitus; effects of improved metabolic control and vitamin E supplementation. Circulation 99:224-229, 1999.
18. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87:9383-9387, 1990.
19. Patrono C, Fitzgerald GA: Isoprostanes: Potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol 17:2309-2315, 1997.
20. Burstein M, Scholnik HR, Morfin R: Rapid method for the isolation of proteins from human serum by precipitation with polyanions. J Lipid Res 11:583-595, 1970.
21. Ubbink J, Vermaak W, Bissbort S: Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 565:441-446, 1991.
22. Blackburn H, Keys A, Simonsen E, et al: The electrocardiogram in population studies. A classification system. Circulation 21:1160-1175, 1960.
23. MacFarlane PW: Minnesota coding and the prevalence of ECG abnormalities. Heart 84:582-584, 2000.
24. De Bacquer D, de Backer G, Kornitzer M. Prevalences of ECG findings in large population-based samples of men and women. Heart 84:625-633, 2000.
25. Gueret P, Meerbaum S, Zwehl W, et al: Two-dimensional echocardiographic assessment of left ventricular stroke volume: Experimental correlation with thermodilution and cineangiography in normal and ischemic states. Cathet Cardiovasc Diagn 7:247-258, 1981.
26. Balmer H, Mahler F, Do DD, et al: Balloon angioplasty in chronic critical limb ischemia: Factors affecting clinical and angiographic outcome. J Endovasc Ther 9:403-410, 2002.
27. Lassila R, Lepantalo M, Lindfors O: Peripheral arterial disease - natural outcome. Acta Med Scand 220:295-301, 1986.
28. Zouridakis EG, Schwartzman R, Garcia-Moll X, et al: Increased plasma endothelin levels in angina patients with rapid coronary artery disease progression. Eur Heart J 22:1578-1584, 2001.
29. Cesari M, Penninx BWJH, Newman AB, et al: Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study). Am J Cardiol 92:522-528, 2003.
30. Roldán V, Marín F, Blann AD, et al: Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation. Eur Heart J 24:1373-1380, 2003.
31. Siriwardena AK, Ruckley CV: Echocardiography in acute limb ischemia. J R Coll Surg Edinb 36:155-157, 1991.
32. Wolf YG, Landersberg G, Mosseri M, et al: Preoperative dipyridamole-thallium scanning, selective coronary revascularization and long-time survival in patients with critical lower limb ischemia. J Cardiovasc Surg 42:89-95, 2001.
33. Vonhof S, Brost B, Stille-Siegener M, et al: Monocyte activation in congestive heart failure due to coronary artery disease and idiopathic dilated cardiomyopathy. Int J Cardiol 63:237-244, 1998.
34. Kosar F, Varol E, Ileri M, et al: Circulating cytokines and complements in chronic heart failure. Angiology 50:403-408, 1999.
35. Gullestad L, Aukrust P, Ueland T, et al: Effects of high- versus low-dose angiotensin-converting enzyme inhibition on cytokine levels in chronic heart failure. J Am Coll Cardiol 34:2061-2067, 1999.
36. Wiedermann CJ, Beimpold H, Herold M, et al: Increased levels of serum neopterin and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-alpha. J Am Coll Cardiol 22:1897-1901, 1993.
37. Caforio ALP, Goldman JH, Baig MK, et al: Elevated serum levels of soluble interleukin-2 receptor, neopterin and β-2-microglobulin in idiopathic dilated cardiomyopathy: Relation to disease severity and autoimmune pathogenesis. Eur J Heart Failure 3:155-163, 2001.
38. Orús J, Roig E, Perez-Villa F, et al: Prognostic value of serum cytokines in patients with heart failure. J Heart Lung Transplant 19:419-425, 2000.
39. Rudzite V, Skards JI, Fuchs D, et al: Serum kynurenine and neopterin concentrations in patients with cardiomyopathy. Immunol Lett 32:125-129, 1992.
40. Clerico A: Pathophysiological and clinical relevance of circulating levels of cardiac natriuretic hormones: Are they merely markers of cardiac disease? Clin Chem Lab Med 40:752-760, 2002.
41. Stumpf C, Lehner C, Eskafi S, et al: Enhanced levels of CD154 (CD40 ligand) on platelets in patients with chronic heart failure. Eur J Heart Failure 5:629-637, 2003.